| 中国医药制造业国际竞争力评价(一) |
| |
| 引用本文： | 穆荣平 吴灼亮. 中国医药制造业国际竞争力评价(一)[J]. 世界科学技术, 2005, 7(4): 1-8 |
| |
| 作者姓名： | 穆荣平 吴灼亮 |
| |
| 作者单位： | [1]中国科学院科技政策与管理科学研究所,北京100080 [2]《世界科学技术：中医药现代化》社,北京100080 |
| |
| 基金项目： | 中国科学院“科学与社会系列报告”项目：《2005年高技术发展报告》,负责人：穆荣平;国家自然科学基金委项目（79970051）：高技术产业国际竞争力评价方法研究,负责人：穆荣平. |
| |
| 摘 要： | 本文从中国医药制造业的发展现状出发，对中国医药制造业的竞争实力、竞争潜力、竞争环境以及竞争态势进行了综和评价分析；得出经济规模不大已经成为制药我国医药制造业R＆D投入和技术创新能力提升与发展的重要因素的结论，并且提出了提高我国医药制造业国际竞争力需要重点解决的6个关键性的问题。
|
| 关 键 词： | 医药制造业 医药经济 医药工业 竞争力评价 国际竞争力 中国医药 制造业 技术创新能力 竞争实力 评价分析 |
| 收稿时间： | 2005-03-30 |
| 修稿时间： | 2005-06-20 |
Assessment of International Competitiveness of Pharmaceutical Industry in China |
| |
| Mu Rongping and Wu Zhuoliang Institute of Policy and Management Science,Chinese Academy of Sciences,Beijing. Assessment of International Competitiveness of Pharmaceutical Industry in China[J]. World Science and Technology(Modernization of Traditional Chinese Medicine), 2005, 7(4): 1-8 |
| |
| Authors: | Mu Rongping Wu Zhuoliang Institute of Policy Management Science Chinese Academy of Sciences Beijing |
| |
| Affiliation: | Mu Rongping and Wu Zhuoliang Institute of Policy and Management Science,Chinese Academy of Sciences,Beijing,100080 |
| |
| Abstract: | Starting with the status quo of the pharmaceutical industry in China this article makes a comprehensive assessment and analysis of the competitive strength, potential, environment and stance of China's pharmaceutical industry, drawing the conclusion that the country' s moderate scale of pharmaceutical industry has become a vital factor which restrains its investment in R&D and its enhancement and development of the capabilities of technical innovation in pharmaceutical industry, and puts forward six key problems which should necessarily be solved in the improvement of international competitiveness of China' s pharmaceutical industry. |
| |
| Keywords: | pharceutical industry medical economy assessment of competitiveness |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
